Revance Therapeutics, Inc. - COM (RVNC)

Q4 2014 13F Holders as of 12/31/2014

Type / Class
Equity / COM
Number of holders
68
Total Shares
19.8M
Shares change
+962K
Total reported value, excl. options
$335M
Value change
+$8.32M
Put/Call ratio
0
Number of buys
39
Number of sells
-37
Price
$16.94
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.